Kilpatrick Townsend appoints new partner to its life sciences team
Andrew Serafini, a specialist in IP in the life sciences sector, has joined Kilpatrick Townsend & Stockton LLP.
He joins from Fenwick & West LLP and will work in the firm’s IP group’s health and life sciences team as a partner in its Seattle office.
He has experience counselling biotechnology and pharmaceutical companies on IP strategies, as well as helping them to develop patent portfolios in immunology and molecular biology.
He follows Sean DeBruine, who joined the firm’s patent litigation team in Silicon Valley last month.
“I am looking forward to leading Kilpatrick Townsend’s health and life sciences sector in Seattle,” said Serafini.
“The firm’s commitment to life sciences coupled with the firm’s continuing growth in the US, Europe and Asia is a perfect complement to my practice,” he added.
Roger Wylie, managing partner of the firm’s Seattle office, said: “We welcome Andrew back to the firm. He is a pre-eminent leader in Seattle’s thriving health & life sciences community. Andrew’s experience and background further strengthen the firm’s well-respected and deep life sciences team and bolster our presence in Seattle.”
